tiprankstipranks
Helus Pharma (DE:R7E)
FRANKFURT:R7E
Germany Market
R7E
Helus Pharma
RESEARCH TOOLSreports

Helus Pharma (R7E) Financial Statements

5 Followers

Helus Pharma Financial Overview

Helus Pharma's market cap is currently €1.18M. The company's EPS TTM is €-5.01; its P/E ratio is -1.62; Helus Pharma is scheduled to report earnings on June 29, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Jun 25Mar 24Mar 23Mar 22
Income Statement
Total RevenueC$ -62.32MC$ 472.27KC$ -18.15MC$ 251.01KC$ 167.76K
Gross ProfitC$ -62.48MC$ 0.00C$ -18.57MC$ 0.00C$ 0.00
Operating IncomeC$ -197.58MC$ -143.15MC$ -78.84MC$ -51.52MC$ -63.84M
EBITDA-C$ -142.94MC$ -78.58MC$ -51.27MC$ -63.67M
Net IncomeC$ -205.08MC$ -113.14MC$ -78.08MC$ -47.49MC$ -67.63M
Balance Sheet
Cash & Short-Term InvestmentsC$ 220.03MC$ 135.02MC$ 208.99MC$ 16.63MC$ 53.64M
Total AssetsC$ 351.40MC$ 258.62MC$ 302.02MC$ 53.90MC$ 84.06M
Total DebtC$ 0.00C$ 0.00C$ 291.00KC$ 0.00C$ 0.00
Net DebtC$ -220.03MC$ -135.02MC$ -208.70MC$ -16.63MC$ -53.64M
Total LiabilitiesC$ 27.11MC$ 21.42MC$ 10.10MC$ 5.66MC$ 7.91M
Stockholders' EquityC$ 323.88MC$ 237.20MC$ 291.93MC$ 48.23MC$ 76.16M
Cash Flow
Free Cash FlowC$ -186.57MC$ -103.27MC$ -69.62MC$ -50.74MC$ -45.73M
Operating Cash FlowC$ -184.67MC$ -101.30MC$ -68.91MC$ -47.43MC$ -45.21M
Investing Cash FlowC$ -1.89MC$ -1.97MC$ 6.92MC$ -3.31MC$ -770.00K
Financing Cash FlowC$ 274.69MC$ 20.20MC$ 254.51MC$ 13.56MC$ 35.78M
Currency in CAD

Helus Pharma Earnings and Revenue History

Income Statement >

Helus Pharma Debt to Assets

Balance Sheet >

Helus Pharma Cash Flow

Cash Flow >

Helus Pharma Forecast EPS vs Actual EPS

Earnings >